US Patent Issued to HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT on March 17 for "Nucleic acid agents modulating SLAMF6 isoforms" (Israeli Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,100, issued on March 17, was assigned to HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (Jerusalem).

"Nucleic acid agents modulating SLAMF6 isoforms" was invented by Michal Lotem (Reut, Israel), Emma Hajaj (Netanya, Israel) and Galit Eisenberg (Modiin, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to nucleic acid agents modulating the expression of SLAMF6 isoforms, compositions comprising same and methods for their use in immunomodulation. Specifically, provided are splice-switching oligonucleotides and constructs useful in cancer immunotherapy."

The patent was filed on June 23, 2020, under Application No. 17/...